Anuh Pharma Ltd. (ANUHPHR) — NSE Stock Analysis

Sector: Healthcare. Industry: Drug Manufacturers - Specialty & Generic. Share price: ₹80.45.

Company Overview

Anuh Pharma Ltd. is a pharmaceutical company engaged in the manufacturing and distribution of Active Pharmaceutical Ingredients (APIs) and pharmaceutical formulations. Its primary function is to supply these APIs not only for domestic use in India but also for international markets, which makes it a significant player in the pharmaceutical supply chain. Anuh Pharma focuses on various therapeutic categories such as anti-malarial, macrolides, and corticosteroids, which are critical for treating diverse health conditions. The company's commitment to quality and compliance with international standards ensures its products are widely accepted across numerous healthcare markets. As part of the broader healthcare and pharmaceuticals industry, Anuh Pharma Ltd. contributes to the essential task of making effective medicines available. Its operational presence in India, coupled with exports, enhances its market significance, providing critical health solutions globally.

Valuation Snapshot

• Market cap: —
• P/E: —
• P/B: —
• ROE: —

Blanket Finance is not a SEBI-registered investment adviser or research analyst. This content is for educational and informational purposes only.